Stay updated on Immunotherapy for Bladder Cancer Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Bladder Cancer Patients Clinical Trial page.

Latest updates to the Immunotherapy for Bladder Cancer Patients Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, indicating a new revision. The previous version, 2.15.2, has been removed.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe webpage has updated the details of a pilot study evaluating neoadjuvant nivolumab and ipilimumab for muscle-invasive bladder cancer, including a change in the principal investigator from Gopakumar Iyer, MD to Scott Niglio, MD, and the addition of new study dates.SummaryDifference43%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check60 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Immunotherapy for Bladder Cancer Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Bladder Cancer Patients Clinical Trial page.